Disease trends in Vietnam Vietnam’s population will continue to grow during… Disease Trends | In-vitro diagnostics | Infectious Diseases Testing Monitor | Global | Vietnam | IVD Gateway
Disease trends in China China's population has reached its peak and is projected to… Disease Trends | In-vitro diagnostics | Infectious Diseases Testing Monitor | Asia | Infectious Diseases Testing Monitor | IVD Gateway
Point-of-care infectious disease testing market In a recent Q&A interview with Clearstate’s global… In-vitro diagnostics | Point-of-care testing (POCT) | Global | IVD Gateway | Point-of-care testing (POCT)
Are there concerns with the supply chain for point-of-care testing reagents and controls in some parts of the world? In a recent Q&A interview, Clearstate’s global managing… In-vitro diagnostics | Point-of-care testing (POCT) | Global | Point-of-care testing (POCT)
What technology will revolutionise the point-of-care testing market? In a recent Q&A interview, Clearstate’s global managing… In-vitro diagnostics | Point-of-care testing (POCT) | Global | Point-of-care testing (POCT)
How impactful is your exhibitor booth going to be at AACC? Navigating the complex dynamics of conference exhibitions is… In-vitro diagnostics | Uncategorised | Global | IVD Gateway | LabPRO Plus | Size and Share Plus
Driving better diagnostic discovery for patients with Rebecca Middleton, vice chair of the participant panel at Genomics England The impact of genomics on global healthcare is one to watch.… In-vitro diagnostics | Next Generation Sequencing (NGS) | Uncategorised | Europe | IVD Gateway | Next Generation Sequencing (NGS)
Enabling faster diagnosis of rare diseases: Interview with HBA Support’s Rebecca Middleton As global research and the understanding of genomics grows… In-vitro diagnostics | Next Generation Sequencing (NGS) | Uncategorised | Europe | IVD Gateway | Next Generation Sequencing (NGS)
The future of thalassemia care The impact of genomics on global healthcare is one to watch.… In-vitro diagnostics | Next Generation Sequencing (NGS) | IVD Gateway | Next Generation Sequencing (NGS)
Building a market access blueprint for lung cancer diagnostics in Asia-Pacific Lung cancer is the leading cause of cancer mortality in the… Cancer diagnostics | Centralised Diagnostics (CEDx) | In-vitro diagnostics | Molecular Diagnostics (MDx) | Asia | Global | Centralised Diagnostics (CEDx) | IVD Gateway | Molecular Diagnostics (MDx)
Launching a new value proposition for core lab solutions An IVD multinational company is preparing to roll out a new… Centralised Diagnostics (CEDx) | In-vitro diagnostics | Americas | Asia | Europe | Global | Middle East & Africa | Centralised Diagnostics (CEDx) | IVD Gateway
Uncovering opportunities faster with IVD Size & Share Plus In dynamic market segments such as infectious disease… In-vitro diagnostics | Global | IVD Gateway | Size and Share Plus